查詢結果分析
來源資料
相關文獻
- 心房顫動治療的新進展
- 人工智慧訊號分析輔助導管電氣燒灼術治療心房顫動
- Sudden Cardiac Death Following Verapamil in a Patient with Wolff-Parkinson-White Syndrome and Dilated Cardiomyopathy--A Case Report and Literature Review Based on Emergency Viewpoints
- 心房顫動的最新治療
- Late Development of Persistent Atrial Fibrillation with Loss of AAI Mode Pacemaker Function and Superior Vena Cava Syndrome--Report of a Case of Sick Sinus Syndrome with Such Complications and Review of Literature
- Electrical Remodeling in Atrial Fibrillation
- 非瓣膜性心房顫動的腦中風預防
- 心房顫動病例及用藥討論
- 手術期間的心房顫動
- Electrosurgical Injuries in Laparoscopy
頁籤選單縮合
題 名 | 心房顫動治療的新進展=Update in Atrial Fibrillation Treatment |
---|---|
作 者 | 游治節; | 書刊名 | 臺灣醫學 |
卷 期 | 24:2 2020.03[民109.03] |
頁 次 | 頁173-178 |
專 輯 | 心房顫動的抗栓治療 |
分類號 | 415.318 |
關鍵詞 | 心房顫動; 竇律控制; 室律控制; 電燒手術; Atrial fibrillation; Rhythm control; Rate control; Ablation; |
語 文 | 中文(Chinese) |
中文摘要 | 心房顫動是心房的電氣訊號紊亂,導致心房失去健康,進而影響整顆心臟以及全身的疾病,雖然我們很想要控制心律,也就是竇律控制,但苦於沒有好而安全的方法可達到這個目的,退而求其次的策略就是室律控制,保住心臟的部分功能,並用抗凝血劑作中風預防。然而隨著我們對心房顫動的了解以及科技的進步,越來越多的電燒工具以及方法應運而生,這些新方法的誕生不外乎是為減少手術時間、增加手術成功率、減少手術併發症、減少長期復發率,幫助病患更容易達到竇律控制的目的,不過新的方法和工具總是需要時間來證明它的效果與安全性,我們應該審慎評估,希望能以最小的風險及破壞,為病患謀得最大的利益。 |
英文摘要 | Atrial fibrillation is a disease that has chaotic atrial electrical signals. The rapid atrial firing causes atrial myocardium damage, and eventually affecting the whole heart and the whole body. Though we know the best strategy is to suppress the fibrillation waves and maintain sinus rhythm, we actually do not have good methods or tools to achieve this goal. Instead of rhythm control, we choose rate control to protect at least the ventricles and also use the anti-coagulants for stroke prevention. With more and more understandings about the atrial fibrillation, we now have the tools designed for pulmonary vein isolation. New methods or tools are built for shorter procedure time, higher successful rate, lower recurrence rate and lower complication rate. But for the new methods, it is always time that can prove the efficacy and the safety in a long run. We need to always update ourselves for new clinical data, and always search for the maximum benefit while minimizing the risks for the patients. |
本系統中英文摘要資訊取自各篇刊載內容。